• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
103.35
451074.97
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.85
 

PDS secures SaaS contract with leading US based value retailer
Apr 07,2026

PDS has entered a Sourcing as a Service (SaaS) contract with a leading US based value retailer.

Under this engagement, PDS will provide support through its end-to-end sourcing capabilities, leveraging its global network across vendor management, compliance, and supply chain execution. The customer, a leading value retail chain in the United States with a strong presence across urban and rural markets, offers a wide assortment of everyday essentials including consumables, apparel, home products, and seasonal merchandise at value price points, serving a broad customer base.

The contract is expected to drive sourcing volumes of approximately Rs 450 crore (~$50mn), with potential to scale up gradually.

The engagement will be executed through PDS subsidiary, GSCL under the leadership of Michael Yee, who will play a key role in driving execution. Having been onboarded onto the PDS platform over the past year, Michael Yee, through GSCL, is leading PDS' efforts to scale its US business, with a focus on deepening customer engagement and strengthening PDS' strategic inroads into the US market. The onboarding of this contract represents a meaningful step in that direction, aligned with the Group's strategy of strengthening its presence in key markets through on-ground leadership and execution capabilities.